Immunohistochemistry Market to Expand at an 8.4% CAGR from 2022 to 2032 | Future Market Insights, Inc.

As per Future Market Insights' latest industry analysis, the Immunohistochemistry Market Size is expected to be worth US$ 2.05 billion in 2022 and US$ 4.59 billion by 2032, with a quick CAGR of 8.4% between 2022 and 2032.

The rise in healthcare spending and the surge in interest in living a better life are expected to drive up adoption of immunohistochemistry.

The immunohistochemistry market is expected to grow due to an increase in chronic diseases. As value-based healthcare solutions become more popular, it is expected that demand for immunohistochemistry will skyrocket.

The immunohistochemistry market share is expected to grow as the number of patients with cancer, infectious diseases, and cardiovascular disorders increases, all of which use immunohistochemistry for diagnosis.

The rapid spread of infectious diseases presents a challenge for medical professionals in developing drugs for such unidentified diseases. Immunohistochemistry demand for such diseases is expected to drive immunohistochemistry market growth.

According to the International Diabetes Federation, 463 million people aged 20 to 79 have diabetes worldwide in 2019, with that figure expected to rise to nearly 700 million by 2045.

Immunohistochemistry market growth is expected to be driven by increased R&D in immunohistochemistry-based techniques in the coming years.

Furthermore, the use of immunohistochemistry is expected to increase over the projected period due to an increase in the incidence and prevalence of chronic diseases such as cancer, in which proteins are expected to play a significant role. The immunohistochemistry industry's short-term growth is expected to be hampered by unfavourable reimbursement regulations.

Key Takeaways from Market Study

  • Because antibodies are so important in disease diagnosis and medication testing, the antibodies segment is expected to dominate the immunochemistry market in 2021, accounting for more than 41% of global revenue.
  • In 2021, hospitals and diagnostic laboratories generated more than 71% of total revenue, dominating the immunochemistry market.
  • North America is expected to command more than 39% of global immunochemistry sales in 2021.
  • Asia Pacific is expected to have the fastest CAGR during the forecast period. This is largely due to global players increased geographic presence in Asian markets.

"Increased automation and machine learning deployment in immunohistochemistry (IHC), as well as the release of technologically enhanced IHC solutions, are expected to drive immunohistochemistry market share significantly during the forecast period. The use of immunohistochemistry in disease diagnosis has grown significantly as IHC methods have advanced." Analyst, Future Market Insights

Competitive Landscape

Key immunohistochemistry market players are developing cutting-edge products that will drive immunohistochemistry market growth.

The introduction of these clinical diagnostic markers could aid in the advancement of early cancer medication development in the immuno-oncology field. Due to R&D advancements, the immunohistochemistry market is expected to expand at a faster rate during the forecast period.

The following companies are among the major players in the global immunohistochemistry market: Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Merck KGaA; Danaher Corporation; PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB; Abcam plc., Agilent Technologies, Inc.

Key Segments

By Product:

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining System
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological stains
    • Blocking Sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

By Application:

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

By End-use:

  • Hospitals & Diagnostic Laboratories
  • Research Institutes
  • Others

Click to get detail Research Report@ https://www.futuremarketinsights.com/reports/immunohistochemistry-market

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Aesthetic Medical Devices Market 2022-2032: Advanced R&D Process Strategies

Image
A recently published study by FMI expects the global  Aesthetic Medical Devices Market  to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced and user-friendly devices, as well as the rising desire for cosmetic treatments among individuals. In addition to that, the popularity of minimally invasive and non-invasive aesthetic operations is expanding internationally as a result of loose facial skin, particularly around the eyes, jowls, and cheeks; and dry or roughened skin, among other important changes that occur as a person ages. Furthermore, the demand for aesthetic devices is rising due to the growing popularity of cosmetic operations among those seeking to improve their looks and stand out from the crowd. Key Takeaways from the Market Study FMI projects the global aesthetic medical d
Read more